Correlation Between Nascent Biotech and RespireRx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nascent Biotech and RespireRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Biotech and RespireRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nascent Biotech and RespireRx Pharmaceuticals, you can compare the effects of market volatilities on Nascent Biotech and RespireRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Biotech with a short position of RespireRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Biotech and RespireRx Pharmaceuticals.

Diversification Opportunities for Nascent Biotech and RespireRx Pharmaceuticals

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Nascent and RespireRx is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Biotech and RespireRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RespireRx Pharmaceuticals and Nascent Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Biotech are associated (or correlated) with RespireRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RespireRx Pharmaceuticals has no effect on the direction of Nascent Biotech i.e., Nascent Biotech and RespireRx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Nascent Biotech and RespireRx Pharmaceuticals

If you would invest  5.45  in Nascent Biotech on October 9, 2024 and sell it today you would earn a total of  0.04  from holding Nascent Biotech or generate 0.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy5.0%
ValuesDaily Returns

Nascent Biotech  vs.  RespireRx Pharmaceuticals

 Performance 
       Timeline  
Nascent Biotech 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nascent Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Nascent Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.
RespireRx Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RespireRx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, RespireRx Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Nascent Biotech and RespireRx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nascent Biotech and RespireRx Pharmaceuticals

The main advantage of trading using opposite Nascent Biotech and RespireRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Biotech position performs unexpectedly, RespireRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RespireRx Pharmaceuticals will offset losses from the drop in RespireRx Pharmaceuticals' long position.
The idea behind Nascent Biotech and RespireRx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences